CN103656275A - Chinese medicine composition for treating rhinitis and preparation method thereof - Google Patents
Chinese medicine composition for treating rhinitis and preparation method thereof Download PDFInfo
- Publication number
- CN103656275A CN103656275A CN201310599346.3A CN201310599346A CN103656275A CN 103656275 A CN103656275 A CN 103656275A CN 201310599346 A CN201310599346 A CN 201310599346A CN 103656275 A CN103656275 A CN 103656275A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 241000229143 Hippophae Species 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 claims description 10
- 235000003935 Hippophae Nutrition 0.000 claims description 9
- 241000555712 Forsythia Species 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract description 4
- 235000007317 Avena nuda Nutrition 0.000 abstract 3
- 240000007054 Avena nuda Species 0.000 abstract 3
- 235000021388 linseed oil Nutrition 0.000 abstract 3
- 239000000944 linseed oil Substances 0.000 abstract 3
- 239000002994 raw material Substances 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 201000009890 sinusitis Diseases 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 201000009151 chronic rhinitis Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010002653 Anosmia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010050515 Hyposmia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 235000019559 hyposmia Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicine composition for treating rhinitis, and a preparation method thereof. The Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 10-20 parts of honeycomb, 8-15 parts of linseed oil, 10-20 parts of sea-buckthorn, 8-15 parts of fructus forsythiae and 10-20 parts of hulless oat. Preferably, the Chinese medicine composition for treating rhinitis can be prepared from the following raw material medicines in parts by weight: 15 parts of honeycomb, 12 parts of linseed oil, 15 parts of sea-buckthorn, 10 parts of fructus forsythiae and 15 parts of hulless oat. The preparation method of the Chinese medicine composition for treating rhinitis comprises the following steps: a, adding the fructus forsythiae and the hulless oat in parts by weight into 100 parts of water, boiling for 40-50 minutes, and subsequently filtering; b, crushing the honeycomb and the sea-buckthorn in parts by weight; c, mixing and uniformly mixing the linseed oil in parts by weight, the filtrate of the step a and the mixture of the step b.
Description
Technical field
The invention belongs to Chinese drug preparation technique field, be specifically related to a kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof.
Background technology
Acute and chronic rhinitis, sinusitis are department of otorhinolaryngology commonly encountered diseases, frequently-occurring disease, account for 1/3 of department of otorhinolaryngology Number of Outpatients.Patient Chang Yin headache feeling of fullness in the head, nasal obstruction, pus tears, hyposmia, hypomnesis and affect study and work.
Acute or chronic rhinitis, the sinusitis traditional Chinese medical science claim " cold nasal obstruction ", " stuffy nose ", " nasal sinusitis ", theory of Chinese medical science is thought the etiology and pathogenesis that lung qi virtual loss, space between skin and muscles catharsis, weakened defensive QI, affection of exogenous wind-cold are primary disease, its pathological change and spleen kidney have certain relation, the substantial defeated cloth that depends on temper because of lung qi, and the root of gas is at kidney, the yang-energy of suffering from a deficiency of the kidney is easy to dissipate, and invades pathogenic in ailment said due to cold or exposure is able to.
Drug therapy for rhinitis has chemotherapy and treatment by Chinese herbs, the former is mainly symptomatic treatment, substantially have the medicine that shrinks nose bleeding pipe if ephedrine, Loratadine are as cetirizine etc. and steroid hormone spray nasal preparation, these chemicalses all have side effect in various degree; The latter because side effect is little, be etiological treatment, met preferably the medication demand of clinical patients.The existing herbal species that is used for the treatment of rhinitis, sinusitis is various, but lack the medicine that therapeutic effect is really supported by irrefutable evidence, in the Chinese medicine composition for the treatment of rhinitis, sinusitis, composition is simple mostly, and according to theory of Chinese medical science, the cause of disease of rhinitis, sinusitis is relevant with the virtual loss of the internal organs such as lung spleen kidney, therefore need to carry out for the virtual loss of the internal organs such as lung spleen kidney the compositions of reasonable compatibility, thereby the comprehensively regulating therapeutical effect of giving full play to compound Chinese medicinal preparation is really to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof.
The present invention treats the Chinese medicine composition of rhinitis, by the crude drug of following parts by weight, is made: 10～20 parts, Nidus Vespae, 8～15 parts of oleum linis, 10～20 parts of Fructus Hippophaes, 8～15 parts of Fructus Forsythiaes, 10～20 parts of Hulless oate.
As optimization, the present invention treats the Chinese medicine composition of rhinitis and can be made by the crude drug of following parts by weight: 15 parts, Nidus Vespae, 12 parts of oleum linis, 15 parts of Fructus Hippophaes, 10 parts of Fructus Forsythiaes, 15 parts of Hulless oate.
The present invention treats the preparation method of the Chinese medicine composition of rhinitis, comprises the following steps:
A, the Fructus Forsythiae of described parts by weight, Hulless oate are joined in the water of 100 parts, decoct after 40～50 minutes and filter;
B, the Nidus Vespae of described parts by weight and Fructus Hippophae are smashed to pieces;
C, by the mixture in the filtrate in the oleum lini of described parts by weight, step a, step b, admixed together stirring.
In medicament composing prescription of the present invention, Nidus Vespae dispels the wind and has counteracting toxic substances, parasite killing, pain relieving, antianaphylactic effect; Be used for the treatment of toothache due to dental caries, sore swollen toxin, acute mastitis, scrofula, skin stubborn dermatitis, fungal infection of hand and foot, allergic constitution.
Omega-fatty acid in oleum lini comprises alpha-linolenic acid, DHA, EPA.Modern nutriology shows the nutrition physiology functional analysis of oils and fats, and alpha-linolenic acid is wherein to maintain the life core substance that mankind's brain is evolved.Be the important component that forms human tissue cell, it is to maintain human body to evolve, and the human body keeping fit must fatty acid, participate in vivo phospholipid synthetic, metabolism, be converted into vital activity factor D HA and the EPA of needed by human; Be in life evolutionary process the most substantially, the most original material.
Cough-relieving sea-buckthorn reduces phlegm; Invigorating the stomach and promoting digestion; Promoting blood circulation to remove blood stasis.Main cough with copious phlegm; Pulmonary abscess; Dyspepsia; Abdominal pain due to retention of food; Stomachache; Intestinal is scorching; Amenorrhea; Traumatic injury congestive edema.
Fructus Forsythiae Fructus Forsythiae has broad-spectrum antibacterial action, and staphylococcus aureus, Hayes dysentery bacterium are had to very strong inhibitory action, and other pathogenic bacterium, influenza virus, fungus are had to certain inhibitory action.
Hulless oate can lactogenic, reduce cholesterol, prevention of cardiac, diabetes, the common cardiovascular and cerebrovascular disease of middle-aged and elderly people is had to certain preventive effect, but " nondigestible, unsuitable polyphagia ".All medicine compatibilities in the present invention, treatment rhinitis class disease has outstanding effect.
Advantage of the present invention is that preparation process is simple and easy, especially has no side effect, and each component interaction treatment rhinitis effect is more outstanding.
Relevant clinical data is as follows:
Physical data: patient's case is totally 200 examples, male's 128 examples wherein, women's 72 examples, minimal ages 6 years old, maximum 55 years old age, 29.8 years old mean age.Selection of disease group: acute rhinitis 20 examples, chronic rhinitis 65 examples, acute sinusitis 25 examples, chronic sinusitis 90 examples.
Diagnostic criteria: in the < < disease of tcm Standardization of diagnosis and curative effect > > promulgating with reference to the practical otorhinolaryngology > > of < < and State Administration of Traditional Chinese Medicine, dependent diagnostic standard is drafted: i.e. 1. symptom: have a stuffy nose, suppurate, hyposmia or disappearance, and how with headache, dizzy, feeling of fullness in the head; 2. sign: often flow out with purulent secretion in nasal meatus; 3. auxiliary examination; According to state of an illness some cases, do Ke, the inspection of Fahrenheit X-ray film; Get rid of other pathological changes of nose.
Therapeutic Method: take embodiment 3 medicines, three times on the one, each 30 grams, 30 days courses for the treatment of, matched group is taken four of BIYANKANG one time three times on the one, 30 days courses for the treatment of.
Criterion of therapeutical effect: the < < disease of tcm Standardization of diagnosis and curative effect > > with reference to the practical otorhinolaryngology > > of < < and State Administration of Traditional Chinese Medicine's promulgation drafts: effective: the transference cures such as headache after the 6d that takes medicine, nasal obstruction, pus tears, sign is obviously improved, rinse pus and obviously reduce or disappear, nasal sinuses X-ray film improves.Effective: symptom is clearly better, sign makes moderate progress, rinse pus reduce (from +++ → ++ →+) or pus from yellow, become white.Invalid: sings and symptoms is not improved.
After case treatment, curative effect statistical result is as follows:
The specific embodiment
The invention will be further described for embodiment plan given below; but can not be interpreted as it is limiting the scope of the invention; according to the present invention, content, to nonessential improvement and adjustment more of the present invention, still belongs to protection scope of the present invention to those skilled in the art.
Embodiment 1:a, get 80 grams of Fructus Forsythiaes, 100 grams of Hulless oate, join in the water of 1000 grams, decoct after 40 minutes and filter; B, get 100 grams, Nidus Vespae, 100 grams of Fructus Hippophaes are smashed to pieces; C, by 80 grams of the oleum linis of described parts by weight, the filtrate in step a, the mixture in step b, admixed together stirring.
Embodiment 2:a, get 150 grams of Fructus Forsythiaes, 200 grams of Hulless oate, join in the water of 1000 grams, decoct after 50 minutes and filter; B, get 200 grams, Nidus Vespae, 200 grams of Fructus Hippophaes are smashed to pieces; C, by 150 grams of the oleum linis of described parts by weight, the filtrate in step a, the mixture in step b, admixed together stirring.
Embodiment 3:a, get 100 grams of Fructus Forsythiaes, 150 grams of Hulless oate, join in the water of 1000 grams, decoct after 45 minutes and filter; B, get 150 grams, Nidus Vespae, 150 grams of Fructus Hippophaes are smashed to pieces; C, by 120 grams of the oleum linis of described parts by weight, the filtrate in step a, the mixture in step b, admixed together stirring.
Claims (3)
1. a Chinese medicine composition for the treatment of rhinitis; It is characterized in that being made by the crude drug of following parts by weight:
Nidus Vespae 10～20 minutes, 8～15 parts of oleum linis, 10～20 parts of Fructus Hippophaes, 8～15 parts of Fructus Forsythiaes, 10～20 parts of Hulless oate.
2. Chinese medicine composition according to claim 1; It is characterized in that being made by the crude drug of following parts by weight: 15 parts, Nidus Vespae, 12 parts of oleum linis, 15 parts of Fructus Hippophaes, 10 parts of Fructus Forsythiaes, 15 parts of Hulless oate.
3. a method of preparing Chinese medicine composition described in claim 1, is characterized in that comprising the following steps:
A, the Fructus Forsythiae of described parts by weight, Hulless oate are joined in the water of 100 parts, decoct after 40～50 minutes and filter;
B, the Nidus Vespae of described parts by weight and Fructus Hippophae are smashed to pieces;
C, by the mixture in the filtrate in the oleum lini of described parts by weight, step a, step b, admixed together stirring.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310599346.3A CN103656275B (en) | 2013-11-25 | 2013-11-25 | A kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310599346.3A CN103656275B (en) | 2013-11-25 | 2013-11-25 | A kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103656275A true CN103656275A (en) | 2014-03-26 |
| CN103656275B CN103656275B (en) | 2015-08-26 |
Family
ID=50295833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310599346.3A Expired - Fee Related CN103656275B (en) | 2013-11-25 | 2013-11-25 | A kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103656275B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366607A (en) * | 2011-08-30 | 2012-03-07 | 高永从 | Traditional Chinese medicine lavipeditum agent for treating allergic rhinitis |
| CN102860445A (en) * | 2012-09-19 | 2013-01-09 | 江苏江大源生态生物科技有限公司 | Preparation method for honeycomb element cream |
-
2013
- 2013-11-25 CN CN201310599346.3A patent/CN103656275B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366607A (en) * | 2011-08-30 | 2012-03-07 | 高永从 | Traditional Chinese medicine lavipeditum agent for treating allergic rhinitis |
| CN102860445A (en) * | 2012-09-19 | 2013-01-09 | 江苏江大源生态生物科技有限公司 | Preparation method for honeycomb element cream |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103656275B (en) | 2015-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463539B (en) | A kind of medicine for the treatment of eczema and its production and use | |
| CN103006788B (en) | External Chinese medicinal preparation for treating rhinitis | |
| CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
| CN102198236A (en) | Chinese medicine composition for treating acute sinusitis and preparation method thereof | |
| CN103110730B (en) | Perillaseed-radix scutellariae-almond decoction for treating asthma and preparation method thereof | |
| CN103656275B (en) | A kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof | |
| CN106581256A (en) | Traditional Chinese medicinal composition for treating nasosinusitis, medicinal preparation for treating nasosinusitis, and preparation method of medicinal preparation | |
| CN103251701B (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN102973547B (en) | Traditional Chinese medicine patch for treating digestive system diseases | |
| CN102727675B (en) | Traditional Chinese medicine capsules used for treating nasal sinusitis | |
| CN102258589B (en) | Deer blood medicinal wine for treating rheumatoid arthritis | |
| CN101979056A (en) | Traditional Chinese medicament for treating asthma | |
| CN105770339A (en) | Medicament for treating acnes | |
| CN105641057A (en) | Medicine composition for treating primary glomerular hematuria caused by failure of spleen to control blood vessels | |
| CN104906375B (en) | A kind of Chinese medicine composition for treating Qi dysfunction in blood control type purpura | |
| CN105031556A (en) | Chinese herb preparation for treating cough variant asthma | |
| CN105748583A (en) | An encapsulated vagina cleaning liquid and a preparing process thereof | |
| CN104274594B (en) | One is treated prosopalgic Chinese medicine preparation | |
| CN103768573B (en) | A kind of spleen-stomach deficiency-cold eye for the treatment of is shed tears the Chinese medicine composition of pruritus | |
| CN101293004B (en) | Medicament for treating chyluria | |
| CN103845710A (en) | Traditional Chinese medicine for treating intestinal ascariasis | |
| CN115429859A (en) | Traditional Chinese medicine composition for treating skin pruritus diseases and preparation method and application thereof | |
| CN110227104A (en) | The traditional Chinese powder medicine for treating pneumonia | |
| CN102626503A (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN107929456A (en) | Treat spray of nasal polyp and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: CHEN WENLI Free format text: FORMER OWNER: ZHANG XIULI Effective date: 20150727 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Wenli Inventor before: Zhang Xiuli |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG XIULI TO: CHEN WENLI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150727 Address after: 272600 Department of ENT, Liangshan County People's Hospital, Jining, Shandong Applicant after: Chen Wenli Address before: 042600 in Shanxi city of Linfen province Fushan County Road No. 178 Applicant before: Zhang Xiuli |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150826 Termination date: 20171125 |